Your Rx for answers and savings: Ask a pharmacist

2018-03-07T16:01:00

(BPT) – There’s no denying that prescription drug coverage and medications can be complex territory.

Enter UnitedHealthcare Medicare & Retirement’s Chief Pharmacy Officer Mike Anderson, PharmD, who has spent his career navigating the ins and outs of the Rx world.

Below, Anderson answers some common questions people ask about drug coverage and prescriptions.

Q. What’s the difference between PDP and MA-PD plans?

A. Original Medicare doesn’t provide coverage for most prescription drugs, so for help paying for medications, you have two options: a standalone Part D prescription drug plan (PDP) in addition to Original Medicare or Original Medicare and a Medicare supplement plan; or a Medicare Advantage plan with prescription drug coverage (MAPD). Medicare Advantage plans can include additional benefits like dental, vision and hearing coverage, and combine your coverage into a single plan. Both plans are offered by private insurance companies contracted by Medicare.

Q. How do I know if my prescriptions are covered by my Medicare plan?

A. Whether you get coverage through Medicare Advantage or a standalone Part D plan, each has a formulary, a list of prescription drugs covered. You’ll want to look closely to make sure your medications are covered. Health insurers post plan formularies online, or you can call your plan to request a printed version. Keep in mind that plans can change from year to year, so don’t assume that prescription drugs covered this year will always carry over.

Q. How can I save money while remaining on my medications?

A. There are many ways to do that:

Home-delivery pharmacy benefits can save money and a trip to the pharmacy. Some mail-order pharmacies offer the convenience of ordering a three-month supply of drugs delivered to your home for less than purchasing at a retail location.

If you prefer to visit a pharmacy, check if your plan offers programs or preferred pharmacy networks to help you save on prescriptions.

Switching to generic drugs or drugs on a lower tier of the formulary is another step that could save money. If you are taking brand-name medications now, discuss generic alternatives with your doctor.

Q. Can I split my pills in half?

A. Talk to your doctor about whether pill-splitting for your medication is medically advised. Also, consult your pharmacist on whether the actual pill form presents risks. Some pills are dangerous when split, because splitting affects how quickly the drug is released into your body. Other pills become ineffective when split, because the pill contains a coating to protect it from stomach acid, and splitting the pill breaks that coating.

Q. I take a lot of pills daily. One I take three times a day. Some I just take once. I get busy and forget to take my pills. Can I just take them all in the morning?

A. It’s important to take your medicine as your doctor prescribed it. Some medications need to be taken at specific times to be effective. Plus, taking all your medications at one time can be dangerous as you run the risk of potential adverse interactions, side effects and even overdosing.

Q. I drink smoothies with supplements and take vitamins. Can these have a bad interaction with my prescriptions?

A. That’s a great question. If an iron supplement was added to the smoothie, for example, that could reduce the effectiveness of thyroid medication and medication for reflux disease. Talk to your pharmacist and doctor about vitamins and supplements to learn if they could cause a reaction or make your medications less effective.

Q. I just got my medication refilled. It used to be a different color and shape. Why does it look different?

A. More than likely, the pharmacy you use bought their supply from a different manufacturer. Drug companies that make the same medication must keep the chemical formula the same but may change the shape or color. As long as you verify it’s the same medication and dose, it should work just like before. If you have concerns, talk with your pharmacist.

For more information to help you navigate prescription drug coverage, visit MedicareMadeClear.com.


With matters of the heart, don’t wait to take action

2018-03-07T11:31:00

(BPT) – The majority of Americans wouldn’t think that walking to their car after work is a difficult task, but that wasn’t the case for Michele Norris. Before her heart failure diagnosis and treatment, Michele found herself leaning on a co-worker while walking to her vehicle, taking frequent breaks along the short route.

She knew something wasn’t right. Michele, a 62-year-old budget director, noticed shortness of breath and swelling in her legs, limiting her daily routines. She decided to take action and talk to her doctor. After a few conversations, Michele was eventually diagnosed with heart failure with reduced ejection fraction, or HFrEF, a chronic and progressive condition affecting millions of Americans, though few know much about it. After discussions with her cardiologist, Michele was prescribed ENTRESTO® (sacubitril/valsartan), a heart failure medicine that helps improve the heart’s ability to pump blood to the body.

“Being diagnosed with heart failure was terrifying, but I learned how to trust my gut, and raise a flag when something feels off,” said Michele. “Taking steps to change my diet and stay active, and adding ENTRESTO to my regimen has helped me stay out of the hospital, although everyone’s experiences are different.”

Michele is passionate about helping others with HF and encourages them to keep all of their doctor appointments, and to be an active partner with their doctors when choosing a treatment plan – which includes medication and lifestyle changes.

Learn more at www.entresto.com

What is ENTRESTO?

ENTRESTO (sacubitril/valsartan) tablets 24/26 mg, 49/51 mg, 97/103 mg is a prescription medicine used to reduce the risk of death and hospitalization in people with certain types of long-lasting (chronic) heart failure. ENTRESTO is usually used with other heart failure therapies, in place of an ACE inhibitor or other ARB therapy.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about ENTRESTO?

ENTRESTO can harm or cause death to your unborn baby. Talk to your doctor about other ways to treat heart failure if you plan to become pregnant. If you get pregnant while taking ENTRESTO, tell your doctor right away.

Who should not take ENTRESTO?

Do not take ENTRESTO if you

  • are allergic to sacubitril or valsartan or any of the ingredients in ENTRESTO
  • have had an allergic reaction including swelling of your face, lips, tongue, throat (angioedema) or trouble breathing while taking a type of medicine called an angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB)
  • take an ACE inhibitor medicine. Do not take ENTRESTO for at least 36 hours before or after you take an ACE inhibitor medicine. Talk with your doctor or pharmacist before taking ENTRESTO if you are not sure if you take an ACE inhibitor medicine
  • have diabetes and take a medicine that contains aliskiren

What should I tell my doctor before taking ENTRESTO?

Before you take ENTRESTO, tell your doctor about all of your medical conditions, including if you have kidney or liver problems or a history of hereditary angioedema; are pregnant or plan to become pregnant; are breastfeeding or plan to breastfeed. You should either take ENTRESTO or breastfeed. You should not do both.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your doctor if you take potassium supplements or a salt substitute; nonsteroidal anti-inflammatory drugs (NSAIDs); lithium; or other medicines for high blood pressure or heart problems such as an ACE inhibitor, ARB, or aliskiren.

What are the possible side effects of ENTRESTO?

ENTRESTO may cause serious side effects including:

  • angioedema that may cause trouble breathing and death. Get emergency medical help right away if you have symptoms of angioedema or trouble breathing. Do not take ENTRESTO again if you have had angioedema while taking ENTRESTO. People who are Black or who have had angioedema and take ENTRESTO may have a higher risk of having angioedema
  • low blood pressure (hypotension). Call your doctor if you become dizzy or lightheaded, or you develop extreme fatigue
  • kidney problems
  • increased amount of potassium in your blood

The most common side effects were low blood pressure, high potassium, cough, dizziness, and kidney problems.

Please see full Prescribing Information, including Boxed WARNING, available at: https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/entresto.pdf.

Patients are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


Results are clear: BPA is safe

2018-03-14T16:09:00

For more than 10 years, U.S. government scientists have been conducting an in-depth research program with the goal of answering key scientific questions and resolving remaining uncertainties about the safety of BPA.
This research so far has shown: that human exposure to BPA is low, that people quickly eliminate BPA from their bodies after exposure and that BPA is unlikely to cause health effects at the low levels to which we’re exposed.
If that’s not enough already, the U.S. National Toxicology Program (NTP) released the results of the capstone study of the full research program, known as the CLARITY Core study. It’s the largest study ever conducted on BPA, and the results indicate that BPA has little potential to cause health effects even when people are exposed to it throughout their lives.
In a statement released in conjunction with the report, Dr. Steven Ostroff, Deputy Commissioner for Foods and Veterinary Medicine at the U.S. Food and Drug Administration (FDA) noted: “… our initial review supports our determination that currently authorized uses of BPA continue to be safe for consumers.”
In the study, laboratory animals were exposed to a range of BPA doses from pregnancy, through early-life development and continuing through their entire lifetime. As stated in the conclusion of the study report, BPA produced minimal effects that were distinguishable from background.”
The study was conducted by scientists with FDA’s National Center for Toxicological Research with funding from NTP as part of the CLARITY program (Consortium Linking Academic and Regulatory Insights on BPA Toxicity). The report was issued in draft form and will next undergo peer-review by a panel of experts organized by NTP. The report will then be finalized and the results are expected to be published in the scientific literature.
Based on the body of U.S. government research already available, the consensus of government bodies around the world is that BPA is safe as currently used. Now with the results of the CLARITY core study, the results validate the FDA’s response to the question Is BPA safe? – Yes.


Chronic anemia: It’s more than meets the eye

2018-03-14T14:17:00

(BPT) – One in every four people is affected by anemia, a condition that occurs when the body lacks enough healthy red blood cells.1,2 Red blood cells carry hemoglobin, a protein that transports oxygen throughout the body, ensuring the body has energy and can function properly.3 Symptoms may vary in severity and can be acute or chronic. Further, many patients present with chronic anemia as a result of other health conditions — cancer, autoimmune and inflammatory diseases, or blood or bone marrow disorders — which each come with their own challenges.2,4,5 For those with chronic anemia associated with other diseases, life after diagnosis often means adjusting to a new “normal.” Dizziness, trouble breathing and overall tiredness experienced by many with anemia may mean adjusting work schedules, changing exercise regimens, limiting social activities and generally slowing down.2

Kathleen Weis, chief executive officer of The Aplastic Anemia and MDS Awareness International Foundation, calls it the “elephant in the room.”6

“Chronic anemia impacts a person’s daily activities. For many, it means not being able to do the things they used to — like going to work or helping around the house. Symptoms, fatigue in particular, can be debilitating,” Weis explained.6

For patients, this may necessitate relinquishing aspects of independence. An increasing reliance on caregivers is one of the hardest transitions people living with chronic anemia face. It’s an entirely new learning process and is often coupled with the guilt of knowing there’s an added burden on family members and caregivers. Patients may even experience depression at one point or another.7

“It’s a double whammy in terms of emotions. Both patients and caregivers are learning how to deal with the changes,” Weis said. “We put a lot of focus on mindfulness and positivity to help patients and their families through these challenges, in addition to educating about treatment. We believe in treating the body and mind together.”6

This March marks the first ever Aplastic Anemia and MDS Awareness Month, an extension from the weeklong observance The Aplastic Anemia and MDS Awareness International Foundation has organized in previous years. Webinars and conferences throughout the month will offer learning opportunities on a wide variety of topics for patients, caregivers and healthcare providers.

Research is another core focus for the Foundation. Treatment options for patients with chronic anemia are limited, and the organization is trying to make sure researching new approaches is seen as a priority. One of the most common treatments is red blood cell transfusions; a process by which donated blood is infused into a patient’s bloodstream.2 Frequency of transfusions depends on disease severity, but some patients may need to be transfused as often as every two weeks.2,8 This is challenging as transfusions are cumbersome, costly and associated with risks.

“Frequent blood transfusions require numerous visits to the doctors, which can be inconvenient for both patients and their caregivers. We would like to see new treatments that not only improve patient outcomes, but may also address current burdens,” said Weis.6

Despite the challenges they face, Weis notes that the patients she meets are resilient. “They want you to know they are still very much moving forward and this thing — this disease — is just something they are dealing with each day.”6

For more information about The Aplastic Anemia and MDS Awareness International Foundation or Aplastic Anemia and MDS Awareness Month, visit http://www.aamds.org/.

REFERENCES:

  1. Pasricha, SR. Anemia: A Comprehensive Global Estimate. Blood. 2014;123(5).
  2. American Cancer Society. Anemia in People With Cancer. Available at https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/low-blood-counts/anemia.html. Accessed March 2018.
  3. American Cancer Society. Blood Transfusions for People with Cancer. Available at https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/blood-transfusion-and-donation/what-are-transfusions.html. Accessed March 2018.
  4. Smith, Jr., R,E. The Clinical and Economic Burden of Anemia. Am J Manag Care. 2010; 16:S59-S66.
  5. Gunnar Birgegård. Managing Anemia in Lymphoma and Multiple Myeloma. Therapeutics and Clinical Risk Management. 2008;4(2):527–539.
  6. Interview with Kathleen Weis. Conducted by Marissa Vitha and Danielle Kroft for the Celgene Newsroom, January 2018.
  7. Korkmaz S, Yildiz, S, et al. Frequency of anemia in chronic psychiatry patients. Neuropsychiatr Dis Treat. 2015;11:2737–2741. doi: 10.2147/NDT.S91581.
  8. Langhi, Jr., D., et.al. Guidelines on Beta-thalassemia major – regular blood transfusion therapy: Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associac¸ão Médica Brasileira – 2016. Brazilian Journal of Hematology and Hemotherapy. 2016;3:8(4):341–345.


Couple Inspires Others with Progressive Forms of Multiple Sclerosis (MS)

2018-03-14T11:31:01

(BPT) – More than 20 years ago, as Jennifer Digmann focused on completing her coursework and graduating from college, she began experiencing numbness in her hands and feet and eventually double vision.

After several visits to her primary care doctor, an ophthalmologist and finally a neurologist, she received the diagnosis: multiple sclerosis (MS).

Today, Jennifer lives with a progressive form of MS, a chronic disease that often strikes in the prime of life, has no cure and is the leading cause of non-traumatic disability in young adults. Progressive forms of MS are the most debilitating. Like others who are affected, Jennifer’s symptoms have continued to worsen over time and her level of disability has increased.

Approximately 400,000 people in the U.S. are living with MS, according to the Multiple Sclerosis Association of America. Up to 15 percent are diagnosed with a progressive form of the disease (called Primary Progressive MS), and the majority of those diagnosed with Relapsing MS will transition to a progressive form later in life, according to the National Multiple Sclerosis Society.

For Jennifer, handling her sadness and fear and accepting her diagnosis was almost as challenging as her symptoms. People living with progressive forms of MS tend to experience more difficulties with walking and remaining in the workforce, and they require more assistance with everyday activities, according to the National Multiple Sclerosis Society.

Progressive forms of MS remain frustratingly difficult to treat, primarily because doctors do not fully understand why the disease progresses. Also, many clinical trials for new medicines have been unsuccessful. More research is needed to better understand the underlying biology driving this condition, as well as to develop additional treatment options.

On March 28, 2018, the first ever Progressive MS Day was celebrated by several MS advocacy groups and state governments around the country. This annual day of awareness was created with the goal of recognizing people living with progressive forms of MS, offering support, highlighting resources, programs and services, and, most importantly, calling for further research to advance their care and reduce disability.

Jennifer and her husband, Dan, who himself lives with Relapsing MS, count themselves among the most enthusiastic supporters of Progressive MS Day. As a couple, the Digmanns have dedicated their lives to inspiring and helping others living with MS by sharing their own experiences and perspectives through their blog and radio show.

“My life is not perfect always, but it’s pretty darn good. This disease, my multiple sclerosis, doesn’t hold me back,” says Jennifer.

Seeing the challenges that Jennifer faces with her condition made Dan excited about Progressive MS Day. “Finally, there’s something for people with the progressive forms of MS. Now, hopefully, that opens the door for more awareness and resources, and that’s why a day like this is pivotal,” says Dan.


Living a Rare Life: Could Your Family History Unlock the Mystery of a Rare, Life-Threatening Condition?

2018-03-13T16:07:01

(BPT) – Imagine your family carried the gene for a rare, life-threatening condition, but didn’t know it?

For generations, members of Angel’s family experienced fatigue, nerve pain, numbness in limbs, dizziness, shortness of breath and chest pain, but were unable to determine the cause. The answer was hereditary ATTR (hATTR) amyloidosis, a progressive, debilitating, life-threatening condition that typically runs in families.

“Early on, my family used to call hATTR amyloidosis ‘the curse’ because no one knew what it was and those who had it experienced a wide variety of symptoms and misdiagnoses,” Angel said. She witnessed firsthand how the condition, which affects approximately 50,000 people worldwide, can devastate a person’s quality of life.

“I watched my grandfather go from building houses and doing construction to being wheelchair bound and bedridden.”

Angel’s family’s experience was recently chronicled in “Living a Rare Life,” a new downloadable booklet sharing their personal account about how they’ve been living with this condition across generations. Like many rare conditions, hATTR amyloidosis varies from individual to individual and is often misdiagnosed because its wide array of symptoms, like shortness of breath, numbness of fingers and toes, constipation/diarrhea and headaches, resemble other, more common conditions.

While the degree and severity of symptoms vary from person to person, hATTR amyloidosis can lead to significant disability and a shortened life expectancy. Obtaining an early and accurate diagnosis is critical.

While Angel tested negative for the condition, she has taken an active role serving as an advocate and caregiver for her family. “The first step to managing a hereditary condition is knowing your family health history and identifying gaps in knowledge about genetic disorders,” said Angel. “Today my mom and many of her siblings are battling hATTR amyloidosis, but now we know how to recognize the symptoms and better manage them.”

Here are a few of Angel’s tips to begin conversations with your loved ones about your health history:

  1. Initiate a Dialogue. Having open and honest conversations about family health history may play a role in identifying symptoms sooner, reaching an accurate diagnosis sooner and allowing your loved ones to take control of their health.
  2. Speak to a Genetic Counselor. Genetic counseling can help your family members understand their chances of inheriting a rare disease gene mutation and become familiar with the testing process. A counselor can help your family to understand potential issues related to genetic testing, like insurance, determine if genetic testing is appropriate and help make sense of results once they are obtained.
  3. Become an Advocate. As an advocate, you can be your family’s most valuable resource for learning about a genetic condition. For some family members, it may be helpful for them to know that they have support throughout the journey of the condition. Building a support system can help the entire family continue to make educated decisions.

If you, or someone in your family, experience symptoms consistent with those of hATTR amyloidosis, talk to your doctor and visit hATTRBridge.com for information and resources like the “Living a Rare Life” booklet.

* Angel is partnering with Alnylam Pharmaceuticals to increase awareness of hATTR amyloidosis.


There is an Extended-Release ADHD Treatment Option Available

2018-03-13T16:01:00

(BPT) – An estimated 4.4 percent of adults have Attention Deficit Hyperactivity Disorder (ADHD) in the U.S. — which means that when applied to the full U.S. adult population aged 18 and over, approximately 10.5 million adults are estimated to have ADHD. Medication is not appropriate for all individuals diagnosed with ADHD. ADHD is a neurodevelopmental disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. Many of these adults struggle with symptom management as they go through their day.

On June 20, 2017, the U.S. Food and Drug Administration (FDA) approved MYDAYIS® (mixed salts of a single-entity amphetamine product), an extended-release treatment for ADHD in patients 13 years and older. Mydayis is not for use in children 12 years and younger. In clinical studies, Mydayis demonstrated improved attention up to 16 hours after dosing, beginning at 2 to 4 hours, compared to placebo. Attention was measured using the Permanent Product Measure of Performances (PERMP), a skill-adjusted math test that measures attention in ADHD. Mydayis is now available for appropriate patients by prescription.

Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis. Tell your healthcare provider if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.

Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law.

“The recognition and treatment of ADHD have gone through significant developments in the past 20 years as we’ve come to understand more about how symptoms may impact a patient’s day,” said Dr. Theresa Cerulli, Clinical Instructor at Harvard Medical School. “The availability of multiple, different ADHD treatments, including Mydayis, provides healthcare professionals with different tools they can consider using as part of their patients’ management plans.”

As the understanding of ADHD and the ways it impacts people continues to evolve, it is also important for healthcare professionals to have a range of treatment options to help address the needs of their individual patients. Mydayis provides healthcare professionals with another option for their appropriate patients who may seek an extended-release treatment that helps address their individual needs. People living with ADHD should work with a healthcare professional to determine whether a pharmacological treatment is appropriate for them, and if so, which one helps meet their individual needs.

For more information about Mydayis, talk to your healthcare provider and visit www.MYDAYIS.com.

What is MYDAYIS®?

Mydayis is a prescription medicine for ADHD in patients 13 years and older. Mydayis is not for children 12 years and younger.

IMPORTANT SAFETY INFORMATION

Abuse and dependence. Mydayis, other amphetamine containing medicines, and methylphenidate have a high chance for abuse and can cause physical and psychological dependence. Your healthcare provider should check you or your child for signs of abuse and dependence before and during treatment with Mydayis.

Tell your healthcare provider (HCP) if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. Your HCP can tell you how physical and psychological dependence and drug addiction are different.

Mydayis is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. Keep Mydayis in a safe place to protect it from theft. Never give Mydayis to anyone else, because it may cause death or harm them. Selling or giving away Mydayis may harm others and is against the law.

Who should not take Mydayis?

Do not take Mydayis if you or your child is:

  • allergic to amphetamine or any of the ingredients in Mydayis. See Medication Guide for a list of ingredients.
  • taking or have taken a medicine for depression (monoamine oxidase inhibitor [MAOI]) within the past 14 days.

Serious problems can occur while taking Mydayis. Tell your HCP:

  • if you or your child have heart problems, heart defects, high blood pressure, or a family history of these problems. Sudden death has occurred in people with heart problems or defects taking stimulant medicines. Sudden death, stroke and heart attack have happened in adults taking stimulant medicines. Your HCP should check you or your child carefully for heart problems before starting Mydayis. Since increases in blood pressure and heart rate may occur, your HCP should regularly check these during treatment. Call your HCP or go to the ER right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking Mydayis.
  • if you or your child have mental (psychiatric) problems, or a family history of suicide, bipolar illness, or depression. New or worse behavior and thought problems or new or worse bipolar illness may occur. New psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms may occur. Call your HCP right away if you or your child have any new or worsening mental symptoms or problems during treatment, especially hearing voices, seeing or believing things that are not real, or new manic symptoms.
  • if your child is having slowing of growth (height or weight). The HCP should check your child’s height and weight often while on Mydayis, and may stop treatment if a problem is found. Mydayis is not for children 12 years and younger.
  • if you or your child have circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Fingers or toes may feel numb, cool, painful, sensitive to temperature and/or change color. Call your HCP if you or your child have any of these symptoms or any signs of unexplained wounds appearing on fingers or toes while taking Mydayis.
  • if you or your child have a seizure. Your HCP will stop treatment.
  • if you or your child have symptoms of serotonin syndrome: agitation, hallucinations, coma, or changes in mental status; problems controlling movements or muscle twitching, stiffness, or tightness; fast heartbeat; sweating or fever; nausea, vomiting or diarrhea. Call your HCP or go to the ER if symptoms occur. Serotonin syndrome may occur if Mydayis is taken with certain medicines and may be life-threatening.
  • if you or your child are or become pregnant or plan to become pregnant. It is not known if Mydayis may harm your unborn baby.
  • if you or your child are breastfeeding or plan to breastfeed. You should not breastfeed while taking Mydayis. Mydayis passes into breast milk.

What should I avoid during Mydayis treatment?

  • Avoid drinking alcohol during treatment with Mydayis.

What are possible side effects of Mydayis?

The most common side effects of Mydayis include:

  • trouble sleeping
  • decreased appetite
  • dry mouth
  • increased heart rate
  • anxiety
  • nausea
  • irritability
  • weight loss

For additional safety information, click for Medication Guide and discuss with your healthcare provider.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Mydayis is a registered trademark of Shire LLC.

S33443 01/18


Kidney disease is more common than you think

2018-03-13T08:01:00

(BPT) – Suffering from high blood pressure and diabetes, Gloria Stephens became extremely bloated and could barely walk, so she knew something else was wrong. She soon learned that her kidneys were failing, and she joined the ranks of the 1 in 7 people with kidney disease. Often called a “silent killer,” kidney disease can cause a person to lose up to 90 percent of kidney function and not even know it.

For National Kidney Month this March, Fresenius Kidney Care — a leading dialysis provider with more than 2,400 centers nationwide caring for more than 190,000 people — urges people to understand the symptoms of kidney disease and what to do if you suspect you may be at risk.

“I tell all of my friends and anyone I meet — you’ve got to ask questions,” recommends Gloria, 69, of Jacksonville, Florida, who now goes to a Fresenius Kidney Care center to receive her life-saving dialysis, which filters her blood because her kidneys no longer function effectively. “You’ve got to know what’s going on in your body.”

Here’s what you should keep in mind to protect yourself from kidney disease:

1. Know Your Risk. As Gloria learned, the two leading causes of kidney disease are high blood pressure and diabetes. Other risk factors include family history of kidney failure, kidney stones, smoking, obesity and cardiovascular disease. Your age — especially if you are over 50 — overall health and even ethnicity can also put you at greater risk for kidney disease. If you are African American, Hispanic or Native American, you may be more prone to the risk factors that lead to kidney disease.

2. Recognize the Symptoms. Signs and symptoms of kidney disease often occur after the condition has progressed, so early detection is key to maintaining kidney health. Talk to your doctor immediately if you notice any changes in your urine, or if you’re experiencing fatigue, itching, swelling in your hands or feet, shortness of breath or pain in the small of your back. Make sure your loved ones are aware of the symptoms, too, because they may notice something you don’t.

3. Get Screened Regularly. If you are at risk for kidney disease, you should be screened by your doctor at least once a year, including blood and urine tests like glomerular filtration rate (GFR). Your estimated GFR (eGFR) is calculated using blood as well as taking into consideration age, weight, body size and gender. The earlier kidney disease is detected, the greater the benefit of treatment.

4. Focus on What Matters Most. While there are many reasons to get healthy, you should focus on what’s important to you, whether it’s spending time with family and friends or doing an activity you love. You’re more likely to stick with a care plan if you have a goal.

“There are a number of things you can easily do to get healthier and decrease your risk of kidney disease, starting with regular testing,” says Dr. Jeffrey Hymes, chief medical officer at Fresenius Kidney Care.

After Gloria was diagnosed with kidney disease, she didn’t expect to walk, drive or live alone again. But she draws strength from her family, stays active and is able to do all of those things. “I get myself to do something every day. If you don’t let negative things turn you around, you’ll be successful,” said Gloria, who is active in her sorority and church and volunteers with children. “The person who I think gives me the greatest amount of encouragement is my little 7-year-old grandniece named Kendall. It’s wonderful when you have a little person in your heart and in your life to keep you going.”

“Patients like Gloria show that focusing on what you love is a powerful factor in coping with kidney disease,” says Dr. Hymes. “Kidney patients and their care teams should address both the physical and emotional aspects of their health and focus on their ‘why’ as part of their treatment plan.”

Learn more about kidney disease by visiting www.freseniuskidneycare.com.


8 simple things you can do at home to improve indoor air quality

2018-03-21T08:01:00

(BPT) – A clean house always looks and feels good. But did you know a clean environment goes a long way toward keeping you and your family healthy?

For starters, dust holds dander and pollen, which explains why dust so easily triggers an allergy attack. But common household dust contains other bad stuff you just wouldn’t want to breathe in, such as 45 kinds of toxic chemicals used in consumer products, according to a study by George Washington University. Exposure to these chemicals is linked to cancer, hormone changes, developmental problems and more.

“This does sound quite alarming, but it underlines the importance of maintaining your home’s indoor air quality,” says Tom Tasker, Product Manager, Luxaire heating and cooling. “The good news is all it takes is a few simple things to minimize the dust, dirt and other air-choking particles in your home environment.”

So breathe easy at home with these tips from Luxaire, and almost instantly, you and your family can improve your home’s indoor air quality.

* Weekly vacuuming and mopping is one effective way to reduce the amount of nasal-irritating dust that settles on the floors throughout your home. In high-traffic areas, you may want to vacuum or mop more often. Don’t forget to push beds and other furniture out from the walls so you can collect those dust bunnies as well.

* While dust on hard furniture is easy to see and remove, remember that it also settles on furniture and upholstery. That’s why it’s important to get out the vacuum’s brush attachments every month or so and suction it out of the fabric.

* Turning on your HVAC fan before vacuuming can improve indoor air quality even more. Vacuuming is great at removing dirt and dust that’s directly under the cleaner, but the moving air also stirs up other dust and dirt particles that can later resettle on furniture and other just-cleaned surfaces. The airflow created by the HVAC fan can pull these particles out of your rooms and trap them in the filter.

* Checking your HVAC’s filter on a regular basis is always good practice. But the next time you shop for a replacement filter, be mindful of its MERV rating (Minimum Efficiency Reporting Value). Filters with a higher rating can catch smaller dust particles and other contaminants, keeping them out of your breathing space.

* Make sure fireplaces and wood-burning stoves are properly vented to the outside, away from windows and any heating and air conditioning intakes. This keeps fumes and other unwanted particles from re-entering your home’s HVAC system.

* Minimize the amount of unwanted outdoor particles from coming in so you can keep your airways clear and, hopefully, cut back on vacuuming and dusting. Keep windows closed on windy days, and encourage family and guests to leave their shoes at the door. (For those who feel adverse to going barefoot, keep a bin of inexpensive slippers in many sizes at the ready.)

* Keep humidity at a healthy level. An overly humid home can create the perfect environment for mold and other allergens to thrive, which can make the indoor air extra irritating for allergy sufferers. Invest in a humidity meter and make sure the levels stay within a comfortable, healthy range of 30 to 50 percent humidity.

* Make sure dryer and bathroom fans are venting directly outside. When it’s time to replace these, opt for quiet, energy-efficient models, because they’ll keep things quiet while improving your air quality.

Making the indoor air quality in your home healthy and comfortable always starts with a high quality and well-maintained HVAC system, says Tasker. At the same time, following these tips to manage dust, fumes and other contaminants to your breathing space will let your HVAC system work much more efficiently and effectively. To learn more, visit Luxaire.com.